<?xml version="1.0"?>
<Root>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>1</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the NCI-H23 human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, NCI-H23 is panel number 1, cell number 1</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>3</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the NCI-H226 human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, NCI-H226 is panel number 1, cell number 13</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>5</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the NCI-H322M human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, NCI-H322M is panel number 1, cell number 17</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>7</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the NCI-H460 human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, NCI-H460 is panel number 1, cell number 21</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>9</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the HOP-62 human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, HOP-62 is panel number 1, cell number 26</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>11</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the HOP-18 human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, HOP-18 is panel number 1, cell number 27</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>13</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the HOP-92 human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, HOP-92 is panel number 1, cell number 29</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>15</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the NCI-H522 human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, NCI-H522 is panel number 1, cell number 3</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>17</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the LXFL 529 human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, LXFL 529 is panel number 1, cell number 30</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>19</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the A549/ATCC human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, A549/ATCC is panel number 1, cell number 4</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
  <PC-AssayDescription
      xmlns="http://www.ncbi.nlm.nih.gov"
      xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
      xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
  >
    <PC-AssayDescription_aid>
      <PC-ID>
        <PC-ID_id>21</PC-ID_id>
        <PC-ID_version>1</PC-ID_version>
      </PC-ID>
    </PC-AssayDescription_aid>
    <PC-AssayDescription_aid-source>
      <PC-Source>
        <PC-Source_db>
          <PC-DBTracking>
            <PC-DBTracking_name>DTP/NCI</PC-DBTracking_name>
            <PC-DBTracking_source-id>
              <Object-id>
                <Object-id_str>NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line</Object-id_str>
              </Object-id>
            </PC-DBTracking_source-id>
            <PC-DBTracking_date>
              <Date>
                <Date_std>
                  <Date-std>
                    <Date-std_year>2004</Date-std_year>
                    <Date-std_month>8</Date-std_month>
                    <Date-std_day>15</Date-std_day>
                  </Date-std>
                </Date_std>
              </Date>
            </PC-DBTracking_date>
          </PC-DBTracking>
        </PC-Source_db>
      </PC-Source>
    </PC-AssayDescription_aid-source>
    <PC-AssayDescription_name>NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line</PC-AssayDescription_name>
    <PC-AssayDescription_description>
      <PC-AssayDescription_description_E>Growth inhibition of the EKVX human Non-Small Cell Lung tumor cell line is measured as a screen for anti-cancer activity. Cells are grown in 96 well plates and exposed to the test compound for 48 hours. Compounds are tested at 5 different concentrations and three endpoints are estimated from this dose response curve: GI50, concentration required for 50% inhibition of growth, TGI, the concentration requires for complete inhibition of growth, and LC50, the concentration required for 50% reduction in cell number. These estimates are done by simple linear interpolation between the concentrations that surround the approriate level. If a compound doesn&apos;t cause inhibition to the appropriate level, the endpoint is set to the highest concentration tested. </PC-AssayDescription_description_E>
    </PC-AssayDescription_description>
    <PC-AssayDescription_comment>
      <PC-AssayDescription_comment_E>These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI NSC number. In the NCI numbering system, EKVX is panel number 1, cell number 8</PC-AssayDescription_comment_E>
      <PC-AssayDescription_comment_E>Basically compounds  with LogGI50 (unit M) less than -6 were considered as active. Activity score was based on increasing values of -LogGI50.</PC-AssayDescription_comment_E>
    </PC-AssayDescription_comment>
    <PC-AssayDescription_xref>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_dburl>http://dtp.nci.nih.gov/</PC-XRefData_dburl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_asurl>http://dtp.nci.nih.gov/branches/btb/ivclsp.html</PC-XRefData_asurl>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3335022</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>1462164</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
      <PC-AnnotatedXRef>
        <PC-AnnotatedXRef_xref>
          <PC-XRefData>
            <PC-XRefData_pmid>3051021</PC-XRefData_pmid>
          </PC-XRefData>
        </PC-AnnotatedXRef_xref>
      </PC-AnnotatedXRef>
    </PC-AssayDescription_xref>
    <PC-AssayDescription_results></PC-AssayDescription_results>
    <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
    <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  </PC-AssayDescription>
</Root>